BRIEF-Gilead And Kite Announce Presentation Of Transformative Data In 1L Metastatic Triple-Negative Breast Cancer, Updated Results In Multiple Myeloma And Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer At 2025 ASCO And EHA

Reuters
05-16
BRIEF-Gilead And Kite Announce Presentation Of Transformative Data In 1L Metastatic Triple-Negative Breast Cancer, Updated Results In Multiple Myeloma And Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer At 2025 ASCO And EHA

May 15 (Reuters) - Gilead Sciences Inc GILD.O:

  • GILEAD AND KITE ANNOUNCE PRESENTATION OF TRANSFORMATIVE DATA IN 1L METASTATIC TRIPLE-NEGATIVE BREAST CANCER, UPDATED RESULTS IN MULTIPLE MYELOMA AND EARLY DATA FROM NOVEL INVESTIGATIONAL CAR T-CELL THERAPY TARGETING BRAIN CANCER AT 2025 ASCO AND EHA

Source text: ID:nBw8SXQW4a

Further company coverage: GILD.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10